Patents Represented by Attorney Michael A. Innis

Find this attorney in the Justia Lawyer Directory

  • Interferon-alpha 76
    Patent number: 5098703
    Abstract: A new polypeptide, called IFN-.alpha.76, produced by E. coli transformed with a newly isolated and characterized human IFN-.alpha. gene is described. The polypeptide exhibits interferon activities such as antiviral activity, cell growth regulation, and regulation of production of cell-produced substances.
    Type: Grant
    Filed: September 2, 1982
    Date of Patent: March 24, 1992
    Assignee: Cetus Corporation
    Inventor: Michael A. Innis
  • Interferon-alpha 54
    Patent number: 4975276
    Abstract: A new polypeptide, called IFN-.alpha.54, produced by E. coli transformed with a newly isolated and characterized human IFN-.alpha. gene is described. The polypeptide exhibits interferon activities such as antiviral activity, cell growth regulation, and regulation of production of cell-produced substances.
    Type: Grant
    Filed: September 2, 1982
    Date of Patent: December 4, 1990
    Assignee: Cetus Corporation
    Inventor: Michael A. Innis
  • Interferon-.alpha.61
    Patent number: 4973479
    Abstract: A new polypeptide, called IFN-.alpha.61, produced by E. coli transformed with a newly isolated and characterized human IFN-.alpha. gene is described. The polypeptide exhibits interferon activities such as antiviral activity, cell growth regulation, and regulation of production of cell-produced substances.
    Type: Grant
    Filed: September 2, 1982
    Date of Patent: November 27, 1990
    Assignee: Cetus Corporation
    Inventor: Michael A. Innis